Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
1,771
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses

Jeanna Parsons Leigha Faculty of Health, School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada;b Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada;c Canadian Center for Vaccinology & IWK Health Center, Halifax, Nova Scotia, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8408-674XView further author information
ORCID Icon,
Emily A. FitzGeralda Faculty of Health, School of Health Administration, Dalhousie University, Halifax, Nova Scotia, CanadaView further author information
,
Stephana Julia Mossa Faculty of Health, School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada;d CRISMA Center, Department of Critical Care, University of Pittsburgh, Pittsburgh, USAView further author information
,
Michal S. Cheraka Faculty of Health, School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada;c Canadian Center for Vaccinology & IWK Health Center, Halifax, Nova Scotia, CanadaView further author information
,
Rebecca Brundin-Matherb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
,
Alexandra Doddsa Faculty of Health, School of Health Administration, Dalhousie University, Halifax, Nova Scotia, CanadaView further author information
,
Henry T. Stelfoxb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada;e Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Ève Dubéf Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada;g Département d’anthropologie, Université Laval, Québec, CanadaView further author information
,
Kirsten M. Fiestb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada;h O’Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada;i Department of Psychiatry & Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
,
Donna M. Halperinc Canadian Center for Vaccinology & IWK Health Center, Halifax, Nova Scotia, Canada;j Rankin School of Nursing, St. Francis Xavier University, Antigonish, Nova Scotia, CanadaView further author information
,
Sofia B. Ahmede Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada;k Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
,
Shannon E. MacDonaldl School of Public Health, University of Alberta, Edmonton, Alberta, Canada;m Faculty of Nursing, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Sharon E. Strausn Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada;o Department of Medicine, University of Toronto, Toronto, Ontario, Canada;p Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, CanadaView further author information
,
Terra Mancaq Faculty of Health Disciplines, Athabasca University, Athabasca, Alberta, Canada;r Sociology and Social Anthropology, Dalhousie University, Halifax, Nova Scotia, CanadaView further author information
,
Josh Ng Kamstras Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
,
Andrea Soob Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada;t Alberta Health Services, Calgary, Alberta, CanadaView further author information
,
Shelly Longmoreb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
,
Shelly Kupschb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
,
Bonnie Septb Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information
&
Scott A. Halperinc Canadian Center for Vaccinology & IWK Health Center, Halifax, Nova Scotia, Canada;u Department of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada;v Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaView further author information
 show all
Article: 2316417 | Received 27 Nov 2023, Accepted 06 Feb 2024, Published online: 23 Feb 2024

References

  • Kashte S, Gulbake A, El-Amin SF III, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34(3):711–11. doi:10.1007/s13577-021-00512-4.
  • Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao L. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–53. doi:10.1038/s41562-021-01122-8.
  • Biswas MR, Alzubaidi MS, Shah U, Abd-Alrazaq AA, Shah Z. A scoping review to find out worldwide COVID-19 vaccine hesitancy and its underlying determinants. Vaccines. 2021;9(11):1243. doi:10.3390/vaccines9111243.
  • Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021;71:111–116. doi:10.1016/j.coi.2021.07.003.
  • Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–260. doi:10.1016/j.ijid.2021.11.009.
  • Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, Mizrahi B, Alroy-Preis S, Ash N, Milo R. et al. Protection of BNT162b2 vaccine booster against covid-19 in Israel. N Engl J Med. 2021;385(15):1393–1400. doi:10.1056/NEJMoa2114255.
  • Bagcchi S. The world’s largest COVID-19 vaccination campaign. Lancet Infect Dis. 2021;21(3):323. doi:10.1016/S1473-3099(21)00081-5.
  • Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10(2):e17. doi:10.1016/S2213-2600(21)00559-2.
  • Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE. et al. Homologous and heterologous covid-19 booster vaccinations. N Engl J Med. 2022;386(11):1046–1057. doi:10.1056/NEJMoa2116414.
  • Gobeil S-C, Henderson R, Stalls V, Janowska K, Huang X, May A, Speakman M, Beaudoin E, Manne K, Li D. et al. Structural diversity of the SARS-CoV-2 omicron spike. Mol Cell. 2022;82(11):2050–68.e6. doi:10.1016/j.molcel.2022.03.028.
  • He X, Hong W, Pan X, Lu G, Wei X. SARS‐CoV‐2 omicron variant: characteristics and prevention. MedComm. 2021;2(4):838–845. doi:10.1002/mco2.110.
  • Carreño JM, Alshammary H, Tcheou J, Singh G, Raskin AJ, Kawabata H, Sominsky LA, Clark JJ, Adelsberg DC, Bielak DA. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature. 2022;602(7898):682–688. doi:10.1038/s41586-022-04399-5.
  • Iketani S, Liu L, Guo Y, Liu L, Chan JFW, Huang Y, Wang M, Luo Y, Yu J, Chu H. et al. Antibody evasion properties of SARS-CoV-2 omicron sublineages. Nature. 2022;604(7906):553–556. doi:10.1038/s41586-022-04594-4.
  • Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C, Kurth F, Sander LE, Klein F. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nat Med. 2022;28(3):477–80. doi:10.1038/s41591-021-01676-0.
  • van Riel D, de Wit E. Next-generation vaccine platforms for COVID-19. Nat Mater. 2020;19(8):810–812. doi:10.1038/s41563-020-0746-0.
  • Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, Wang M, Yu J, Bowen AD, Chang JY. et al. Antibody evasion by SARS-CoV-2 omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5. Nature. 2022;608(7923):603–608. doi:10.1038/s41586-022-05053-w.
  • Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–277. doi:10.1007/s10900-020-00958-x.
  • Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, Parsons Leigh J, Hu J, El-Mohandes A. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13(1):3801. doi:10.1038/s41467-022-31441-x.
  • Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021;97:107724. doi:10.1016/j.intimp.2021.107724.
  • Razai MS, Chaudhry UA, Doerholt K, Bauld L, Majeed A. Covid-19 vaccination hesitancy. BMJ. 2021:373. doi:10.1136/bmj.n1138.
  • Wake AD, Wake AD. The willingness to receive COVID-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic”–a systematic review. Risk Man Healthcare Pol. 2021;Volume 14:2609–23. doi:10.2147/RMHP.S311074.
  • Limbu YB, Huhmann BA. Why some people are hesitant to receive COVID-19 boosters: a systematic review. Trop Med Infect Dis. 2023;8(3):159. doi:10.3390/tropicalmed8030159.
  • Lu PJ, Srivastav A, Vashist K, Black CL, Kriss JL, Hung M-C, Meng L, Zhou T, Yankey D, Masters NB. et al. COVID-19 booster dose vaccination coverage and factors associated with booster vaccination among adults, United States, March 2022. Emerg Infect Dis. 2023 Jan;29(1):133–140. doi:10.3201/eid2901.221151.
  • Leigh JP, Moss SJ, White TM, Picchio CA, Rabin KH, Ratzan SC, Wyka K, El-Mohandes A, Lazarus JV. Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries. Vaccine. 2022 07 29;40(31):4081–9. doi:10.1016/j.vaccine.2022.04.097.
  • Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, Mariolis‐Sapsakos T, Kaitelidou D. Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study. J Clin Nurs. 2023 07 01;32(13–14):3943–53. doi:10.1111/jocn.16576.
  • Al-Taie A, Yilmaz Z. Assessment of intention and hesitancy to receive a booster dose of COVID-19 vaccine among community pharmacists using a vaccine hesitancy scale. J Public Health. 2023:1–8. doi:10.1007/s10389-023-01968-4.
  • Zhang L, Wu Y, Jing S, Liu X, Ren T, Liu X, Dai Z, Fu J, Chen X, Xiao W. et al. The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: a multicenter cross-sectional study. Am J Infect Control. 2023. doi:10.1016/j.ajic.2023.11.012.
  • Audulv Å, Hall EOC, Kneck Å, Westergren T, Fegran L, Pedersen MK, Aagaard H, Dam KL, Ludvigsen MS. Qualitative longitudinal research in health research: a method study. BMC Med Res Methodol. 2022 10 01;22(1):255. doi:10.1186/s12874-022-01732-4.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042.
  • World Health Organization. Report of the SAGE working group on vaccine hesitancy. [accessed 2022 February 1]. 2014. 63. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.
  • Anderson C. Presenting and evaluating qualitative research. Am J Pharm Educ. 2010 Oct 11;74(8):141. doi:10.5688/aj7408141.
  • Cristancho S, Watling C, Lingard L. Three principles for writing an effective qualitative results section. J Foc Health Prof Educ Mul Prof. 2021;22(3):110–24. doi:10.11157/fohpe.v22i3.556.
  • Leigh J FE P, Moss SJ, Brundin-Mather R, Dodds A, Stelfox HT, Dubé E, Fiest KM, Halperin D, Ahmed SB, Straus SE. et al. Factors affecting knowledge, beliefs, and behaviour toward COVID-19 vaccine booster doses: a cross-national survey. Can J Public Health. 2023. doi:10.17269/s41997-023-00823-z.
  • Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Of Qual. 2017;16(1):1–13. doi:10.1177/1609406917733847.
  • Kendall J. Axial coding and the grounded theory controversy. West J Nurs Res. 1999;21(6):743–757. doi:10.1177/019394599902100603.
  • Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual. 2006;5(1):80–92. doi:10.1177/160940690600500107.
  • Gallant AJ, Nicholls LAB, Rasmussen S, Cogan N, Young D, Williams L, Gesser-Edelsburg A. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: a longitudinal study of older adults in the UK. PLoS One. 2021;16(12):e0261844. doi:10.1371/journal.pone.0261844.
  • Sprengholz P, Korn L, Eitze S, Felgendreff L, Siegers R, Goldhahn L, De Bock F, Huebl L, Böhm R, Betsch C. et al. Attitude toward a mandatory COVID-19 vaccination policy and its determinants: evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany. Vaccine. 2022;40(51):7370–7377. doi:10.1016/j.vaccine.2022.01.065.
  • Zhang X, Guo Y, Zhou Q, Tan Z, Cao J. The mediating roles of medical mistrust, knowledge, confidence and complacency of vaccines in the pathways from conspiracy beliefs to vaccine hesitancy. Vaccines. 2021;9(11):1342. doi:10.3390/vaccines9111342.
  • Samadipour E, Ghardashi F, Aghaei N. Evaluation of risk perception of COVID-19 disease: a community-based participatory study. Disaster Med Public Health Prep. 2023;17:e10. doi:10.1017/dmp.2020.311.
  • Dolu İ, Turhan Z, Dilcen HY. COVID-19 vaccine acceptance is associated with vaccine hesitancy, perceived risk and previous vaccination experiences. Disaster Med Public Health Prep. 2023;17:e97. doi:10.1017/dmp.2021.370.
  • Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. Lancet. 2011 Aug 6;378(9790):526–35. doi:10.1016/s0140-6736(11)60678-8.
  • Chivese T, Matizanadzo JT, Musa OA, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani TA. et al. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis. Pathog Glob Health. 2022;116(5):269–281. doi:10.1080/20477724.2022.2029301.
  • Dowdy D, D’Souza G. Early herd immunity against COVID-19: a dangerous misconception. Johns Hopkins COVID-19 Res Cen. 2020. https://coronavirus.jhu.edu/from-our-experts/early-herd-immunity-against-covid-19-a-dangerous-misconception.
  • Chavda VP, Chen Y, Dave J, Chen Z-S, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V. et al. COVID-19 and vaccination: myths vs science. Expert Rev Vaccines. 2022;21(11):1603–1620. doi:10.1080/14760584.2022.2114900.
  • Kreps SE, Goldfarb JL, Brownstein JS, Kriner DL. The relationship between US adults’ misconceptions about COVID-19 vaccines and vaccination preferences. Vaccines. 2021;9(8):901. doi:10.3390/vaccines9080901.
  • Enea V, Eisenbeck N, Carreno DF, Douglas KM, Sutton RM, Agostini M, Bélanger JJ, Gützkow B, Kreienkamp J, Abakoumkin G. et al. Intentions to be vaccinated against COVID-19: the role of prosociality and conspiracy beliefs across 20 countries. Health Commun. 2023;38(8):1530–1539. doi:10.1080/10410236.2021.2018179.
  • Pfattheicher S, Petersen MB, Böhm R. Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions. Health Psychol. 2022;41(2):85. doi:10.1037/hea0001096.
  • James EK, Bokemper SE, Gerber AS, Omer SB, Huber GA. Persuasive messaging to increase COVID-19 vaccine uptake intentions. Vaccine. 2021;39(49):7158–7165. doi:10.1016/j.vaccine.2021.10.039.
  • Patel MS, Volpp KG, Asch DA. Nudge units to improve the delivery of health care. N Engl J Med. 2018;378(3):214. doi:10.1056/NEJMp1712984.
  • Rozek LS, Jones P, Menon A, Hicken A, Apsley S, King EJ. Understanding vaccine hesitancy in the context of COVID-19: the role of trust and confidence in a seventeen-country survey. Int J Public Health. 2021;66:636255. doi:10.3389/ijph.2021.636255.
  • Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P. Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies. Expert Rev Vaccines. 2018;17(11):989–1004. doi:10.1080/14760584.2018.1541406.
  • Momplaisir F, Haynes N, Nkwihoreze H, Nelson M, Werner RM, Jemmott J. Understanding drivers of coronavirus disease 2019 vaccine hesitancy among blacks. Clin Infect Dis. 2021;73(10):1784–1789. doi:10.1093/cid/ciab102.
  • Allington D, McAndrew S, Moxham-Hall V, Duffy B. Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic. Psychol Med. 2023;53(1):236–247. doi:10.1017/S0033291721001434.
  • Chou W-Y, Budenz A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020;35(14):1718–1722. doi:10.1080/10410236.2020.1838096.
  • Wiysonge CS, Ndwandwe D, Ryan J, Jaca A, Batouré O, Anya BP, Cooper S. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? Hum Vaccin Immunother. 2022;18(1):1–3. doi:10.1080/21645515.2021.1893062.
  • Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(7):1599–1609. doi:10.1080/21645515.2018.1459252.
  • Ferguson NM, Anderson RM, Garnett GP. Mass vaccination to control chickenpox: the influence of zoster. Proc Natl Acad Sci. 1996;93(14):7231–5. doi:10.1073/pnas.93.14.7231.
  • Domnich A, Orsi A, Trombetta C-S, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals. 2022;15(3):322. doi:10.3390/ph15030322.
  • Tzenios N, TAZANIOS ME, Chahine M. Combining influenza and COVID-19 booster vaccination strategy: a systematic review and meta-analysis. 2022. doi:10.2139/ssrn.4276608.
  • Verger P, Botelho-Nevers E, Garrison A, Gagnon D, Gagneur A, Gagneux-Brunon A, Dubé E. Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Rev Vaccines. 2022;21(7):909–27. doi:10.1080/14760584.2022.2056026.
  • Kwok KO, Li K-K, Wei WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021;114:103854. doi:10.1016/j.ijnurstu.2020.103854.
  • Betsch C, Wicker S. E-health use, vaccination knowledge and perception of own risk: drivers of vaccination uptake in medical students. Vaccine. 2012;30(6):1143–1148. doi:10.1016/j.vaccine.2011.12.021.
  • Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018;13(12):e0208601. doi:10.1371/journal.pone.0208601.
  • Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, Modi H, Pandya S, Sloyan M, Croymans DM. et al. Behavioural nudges increase COVID-19 vaccinations. Nature. 2021;597(7876):404–409. doi:10.1038/s41586-021-03843-2.
  • Ward PR. Improving access to, use of, and outcomes from public health programs: the importance of building and maintaining trust with patients/clients. Front Public Health. 2017;5:22. doi:10.3389/fpubh.2017.00022.
  • Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325–330. doi:10.1007/s10654-020-00634-3.
  • Wilholt T. Epistemic trust in science. Br J Phil Sci. 2013;64(2):233–253. doi:10.1093/bjps/axs007.
  • Vergara RJD, Sarmiento PJD, Lagman JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health. 2021;43(2):e291–e292. doi:10.1093/pubmed/fdaa282.
  • Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. 2021;9(12):1424. doi:10.3390/vaccines9121424.
  • Jairoun AA, Al-Hemyari SS, El-Dahiyat F, Jairoun M, Shahwan M, Al Ani M, Habeb M, Babar ZUD. Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives. J Pharm Policy Pract. 2022 03 28;15(1):26. doi:10.1186/s40545-022-00422-2.
  • Hermanowicz JC. The longitudinal qualitative interview. Qual Sociol. 2013;36(2):189–208. doi:10.1007/s11133-013-9247-7.
  • Calman L, Brunton L, Molassiotis A. Developing longitudinal qualitative designs: lessons learned and recommendations for health services research. BMC Med Res Methodol. 2013;13(1):1–10. doi:10.1186/1471-2288-13-14.
  • Saldaña J. Longitudinal qualitative research: analyzing change through time. Rowman Altamira; 2003.
  • van Wijk E. Recruitment and retention of vulnerable populations: lessons learned from a longitudinal qualitative study. Qual Rep. 2014;19(28). doi:10.46743/2160-3715/2014.1135.
  • Alcendor DJ, Matthews-Juarez P, Smoot D, Edwards A, Hildreth JE, Juarez PD. Vaccine confidence and uptake of the omicron bivalent booster in Tennessee: implications for vulnerable populations. Vaccines. 2023;11(5):906. doi:10.3390/vaccines11050906.
  • Thomson R, Holland J. Hindsight, foresight and insight: the challenges of longitudinal qualitative research. Int J Soc Res Methodol. 2003;6(3):233–244. doi:10.1080/1364557032000091833.
  • Masters NB, Zhou T, Meng L, Lu P-J, Kriss JL, Black C, Omari A, Boone K, Weiss D, Carter RJ. et al. Geographic heterogeneity in behavioral and social drivers of COVID-19 vaccination. Am J Prev Med. 2022;63(6):883–893. doi:10.1016/j.amepre.2022.06.016.
  • Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The health belief model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 2015;30(6):566–76. doi:10.1080/10410236.2013.873363.
  • Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021 05 01;13(2):469–84. doi:10.1111/aphw.12262.
  • Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013;31(40):4293–4304. doi:10.1016/j.vaccine.2013.07.013.
  • Dubé E, Gagnon D, MacDonald NE. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33(34):4191–4203. doi:10.1016/j.vaccine.2015.04.041.
  • Serlachius A, Badawy SM, Thabrew H. Psychosocial challenges and opportunities for youth with chronic health conditions during the COVID-19 pandemic. JMIR Pedia Paren. 2020;3(2):e23057. doi:10.2196/23057.
  • Abbott A, Askelson N, Scherer AM, Afifi RA. Critical reflections on COVID-19 communication efforts targeting adolescents and young adults. J Adolesc Health. 2020;67(2):159–160. doi:10.1016/j.jadohealth.2020.05.013.
  • Sze S, Pan D, Nevill CR, Gray LJ, Martin CA, Nazareth J, Minhas JS, Divall P, Khunti K, Abrams KR. et al. Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2020 Dec;29:100630. doi:10.1016/j.eclinm.2020.100630.
  • Pan D, Sze S, Minhas JS, Bangash MN, Pareek N, Divall P, Williams CM, Oggioni MR, Squire IB, Nellums LB. et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine. 2020 Jun 01;23:100404. doi:10.1016/j.eclinm.2020.100404.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.